Corcept Therapeutics
CORT
$25.06
Share price
4.94%
Change (1 day)
11.92%
Change (1 year)
Categories
Corcept Therapeutics (CORT) Fails to deliver data
Key failure to deliver metrics for Corcept Therapeutics :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.67 M
- Last 3 months FTD volume: $11.56 M
- Last year FTD volume: $18.14 M
Failures to deliver for Corcept Therapeutics (CORT) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Corcept Therapeutics (CORT) - since 2013
Volume in USD (price x number of shares), data since 2013Corcept Therapeutics (CORT) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $11.69 M | 4.3% |
| 2023 | $11.21 M | 14.83% |
| 2022 | $9.76 M | -67.39% |
| 2021 | $29.94 M | 163.11% |
| 2020 | $11.38 M | -51.05% |
| 2019 | $23.25 M | -56.08% |
| 2018 | $52.94 M | 28.02% |
| 2017 | $41.35 M | 73.96% |
| 2016 | $23.77 M | 330.76% |
| 2015 | $5.51 M | 41.23% |
| 2014 | $3.9 M | 65.65% |
| 2013 | $2.35 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $30.58 M | $84.43 M | 🇨🇭 Switzerland |
 Pfizer PFE | $16.08 M | $0.32 B | 🇺🇸 USA |
 Eli Lilly LLY | $53.06 M | $0.12 B | 🇺🇸 USA |
 Merck MRK | $6 M | $0.17 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 MannKind Corp MNKD | $11.24 M | $13.9 M | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $2.85 M | $8.43 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $2.15 M | $7.63 M | 🇺🇸 USA |